F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer - The New York Times
Sentiment Mix
Geography
Expert Signals
CBS News - Top Stories
source • 1 mention
New York Times - Home Page
source • 1 mention
Politics - Google News US Headlines
source • 1 mention
AI-Generated Claims
Generated from linked receipts; click sources for full context.
Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.
Supported by 1 story
Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
Supported by 1 story
Grants Early Access to Promising Drug for Pancreatic Cancer
Supported by 1 story
Related Events
6 Common Medications That May Decrease Dementia Risk
Uncategorized • 5/1/2026
Thinking about peptides? Doctors reveal key dos and don’ts as ‘Wild West’ market grows
Industry • 5/1/2026
Upcoming Public Health Mobile Unit immunization and testing clinics - Nova Scotia Health
Uncategorized • 5/1/2026
Report: Federal government to announce funding for Canada Soccer national training centre - TSN
Policy & Regulation • 5/1/2026
Beloved TV host reveals major medical diagnosis on air, plans to step away for treatment - PennLive.com
Uncategorized • 5/1/2026